Diabetic neuropathies

Schmidt, Robert E.

doi:10.1002/9781118618424.ch28

Search citation statements

Order By: Relevance

Paper Sections

Select...

Comment1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 49 publications

(60 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…"Diabetic Neuropathies" Melissa A. Elafros, MD, PhD, and Brian C. Callaghan, MD, MS, FAAN, 21 in this issue of Continuum.…”

Section: Commentmentioning

confidence: 98%

Autoimmune Axonal Neuropathies

Tracy

2023

CONTINUUM: Lifelong Learning in Neurology

View full text Add to dashboard Cite

Objective This article reviews autoimmune axonal neuropathies, their characteristic clinical features, disease and antibody associations, appropriate ancillary testing, treatment, and prognosis. Latest Developments In 2021, the American College of Rheumatology and the Vasculitis Foundation released new summary guidelines for the treatment of antineutrophil cytoplasmic autoantibody–associated vasculitides. In addition, novel autoantibodies have been recently identified; they are often paraneoplastic and associated with axonal neuropathies. Essential Points Recognition of autoimmune axonal neuropathies is important because of the potential for effective treatment to either reverse deficits or slow the progression of disease. It is necessary to properly assess for associations with other systemic disorders (eg, systemic vasculitis, connective tissue disease, neoplasm) so that adequate treatment for both neurologic and non-neurologic aspects of the disease can be initiated.

show abstract

“…"Diabetic Neuropathies" Melissa A. Elafros, MD, PhD, and Brian C. Callaghan, MD, MS, FAAN, 21 in this issue of Continuum.…”

Section: Commentmentioning

confidence: 98%